Nacuity Pharmaceuticals Receives $16.5 Million Series B Financing to Support its Clinical Trials

Nacuity Pharmaceuticals announced the closing of a $16.5 million Series B financing led by Foundation Fighting Blindness and its venture arm RD Fund. Additional existing investors also participated in the round.

Nacuity Pharmaceuticals Receives $16.5 Million Series B Financing to Support its Clinical Trials
June 16, 2022
Weill Cornell Medicine Receives $1.27m Funding to Develop Treatment for Rare Eye Disease

The US Department of Defense (DoD) has awarded Weill Cornell Medicine a $1.27 million grant to develop a treatment for a rare but deadly eye disease that mostly affects military members who have suffered traumatic eye injuries in combat.

Weill Cornell Medicine Receives $1.27m Funding to Develop Treatment for Rare Eye Disease
November 23, 2021
Schwind Eye-Tech Solutions Receives Funding for Laser Surgery Project

Schwind eye-tech-solutions has received funding for a new research project aimed at developing an ophthalmic laser system with ultra-short laser pulses[1], according to a company announcement.

Schwind Eye-Tech Solutions Receives Funding for Laser Surgery Project
July 26, 2022
More